Adverse Events Following Immunization (AEFI) of COVID-19 Vaccine: A Descriptive Survey in Malang City

Vaccination is used to stop the transmission of COVID-19. However, it can stimulate Adverse Event Following Immunization (AEFI) symptoms, ranging from mild to severe. This study aims to identify the signs and symptoms of AEFI of the COVID-19 vaccine in the Malang City Community. The research design used is a descriptive survey. The sampling technique used was accidental sampling (n=275). The sample criteria were able and willing to fill out the questionnaire by accessing the google form from the researcher. Data were analysed using the Descriptive Statistical Analysis Test. The results of the study indicated that the number of respondents who experienced AEFI after receiving dose 1 vaccine was 97 people (35.2%), with symptoms including fever in 96 people (34.9%), swelling or redness at the injection site in 13 people (4.7%), pain in the injection site in 44 people (16.0%) and 1 person (0.4%) experienced other symptoms that required medical attention. After the second dose of the vaccine, 63 people (22.9%) had a fever, 11 people (4.0%) experienced swelling or redness at the injection site, 18 people (6.5%) experienced pain at the injection site, and 3 people (1.0 %) had other symptoms that required treatment. Signs and symptoms of AEFI of the COVID-19 vaccine most experienced by respondents after vaccine doses 1 and 2 were fever, pain at the injection site, and swelling or redness at the injection site, and there were no severe signs of AEFI were found in this study. Keywords: AEFI, Covid-19 vaccine, signs, symptoms